Detalhe da pesquisa
1.
Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making.
Oncol Ther
; 10(2): 421-440, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35695986
2.
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
JCO Precis Oncol
; 6: e2100372, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35952319
3.
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group.
Clin Cancer Res
; 27(9): 2408-2415, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563637
4.
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement.
Clin Cancer Res
; 27(9): 2394-2399, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563632
5.
A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making.
Am Health Drug Benefits
; 13(3): 110-119, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32699571